GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $65.61 $83.89 Thursday, 18th Apr 2024 AXSM stock ended at $65.72. This is 5.72% less than the trading day before Wednesday, 17th Apr 2024. During the day the stock fluctuated 6.81% from a day low at $65.61 to a day high of $70.08.
90 days $65.61 $98.40
52 weeks $55.03 $98.40

Historical Axsome Therapeutics prices

Date Open High Low Close Volume
2024-04-18 $69.44 $70.08 $65.61 $65.72 834 137
2024-04-17 $69.17 $70.77 $68.16 $69.71 385 143
2024-04-16 $67.41 $70.05 $67.10 $68.81 457 490
2024-04-15 $68.73 $69.30 $66.94 $68.21 423 167
2024-04-12 $71.75 $71.75 $68.28 $69.15 584 054
2024-04-11 $71.11 $71.95 $68.70 $71.73 766 355
2024-04-10 $70.71 $71.60 $70.00 $70.97 571 873
2024-04-09 $72.00 $73.47 $71.80 $72.64 370 496
2024-04-08 $72.06 $72.74 $71.62 $72.11 391 453
2024-04-05 $71.69 $73.49 $71.12 $72.25 369 336
2024-04-04 $73.98 $74.98 $71.58 $72.17 393 102
2024-04-03 $74.45 $74.45 $72.02 $73.50 623 574
2024-04-02 $75.91 $76.12 $74.03 $74.56 645 879
2024-04-01 $79.80 $80.00 $76.06 $76.99 585 127
2024-03-28 $79.62 $79.98 $77.08 $79.80 487 583
2024-03-27 $77.35 $79.25 $74.53 $79.17 473 749
2024-03-26 $78.37 $79.50 $76.49 $76.72 572 373
2024-03-25 $83.40 $83.89 $75.63 $77.35 1 398 281
2024-03-22 $81.52 $82.00 $79.77 $80.66 579 993
2024-03-21 $79.65 $80.98 $78.20 $80.86 839 367
2024-03-20 $76.69 $78.95 $75.52 $78.85 510 158
2024-03-19 $73.15 $77.50 $73.14 $76.87 1 231 279
2024-03-18 $75.60 $75.80 $72.21 $72.54 580 547
2024-03-15 $69.97 $75.60 $69.93 $75.54 1 586 456
2024-03-14 $69.59 $71.37 $68.59 $69.74 875 226
Click to get the best stock tips daily for free!

About Axsome Therapeutics

Axsome Therapeutics Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinical trial to treat Alzheimer's disease agitation, as well as that has completed phase II clinical trial ... AXSM Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT